Topics
CNS Tumors | Treatment | Side effects | Thromboembolism
Home > Publications > Topics > CNS Tumors > Treatment > Side effects > Thromboembolism
Veiga
VC, Peres SV, Ostolin TLVDP, Moraes FR, Belucci TR, Clara CA,
Cavalcanti AB, Chaddad-Neto FEA, Batistella GNR, Neville IS, Baeta
AM, Yamada CAF; TROMBOGLIO Study Group.
Incidence
of venous thromboembolism and bleeding in patients with malignant
central nervous system neoplasm: Systematic review and
meta-analysis.
PLoS
One.
2024 Jun 20;19(6):e0304682. doi:
10.1371/journal.pone.0304682. PMID:
38900739. Review; Meta-Analysis.
ˍ
Yhim HY.
Proper application of
anticoagulation therapy on cancer-associated venous thrombosis.
Blood
Res. 2024 Aug 2;59(1):25. doi:
10.1007/s44313-024-00029-3. PMID:
39093370. Review. ˍ
Hoberstorfer T, Ay C, Riedl J.
Mechanisms
and treatment of venous thromboembolism in patients with brain
cancer: A narrative review.
J
Thromb Haemost. 2025 Nov 2:S1538-7836(25)00722-6. doi:
10.1016/j.jtha.2025.10.022. PMID:
41187830. Review. ˍ
Mahé I, Chapelle C, Girard P, Carrier M, Palomares LJ,
Samama CM, Helfer H, Gerotziafas G, Laporte S, Vicaut E, Mismetti
P; API-CAT Study Group; API-CAT Investigators.
Predictors
of clinically relevant bleeding during extended anticoagulation
for cancer-associated venous thromboembolism (API-CAT): a post-hoc
analysis of a randomised, non-inferiority trial.
Lancet
Haematol. 2025 Dec 6:S2352-3026(25)00291-1. doi:
10.1016/S2352-3026(25)00291-1. PMID:
41365312. Interventional
study˰
ˍ